MannKind Corp (MNKD)
4.62
+0.15
(+3.36%)
USD |
NASDAQ |
Mar 18, 16:00
4.66
+0.04
(+0.87%)
After-Hours: 20:00
MannKind Revenue (TTM): 198.96M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 198.96M |
September 30, 2023 | 176.55M |
June 30, 2023 | 158.12M |
March 31, 2023 | 128.40M |
December 31, 2022 | 99.77M |
September 30, 2022 | 76.23M |
June 30, 2022 | 65.61M |
March 31, 2022 | 70.00M |
December 31, 2021 | 75.44M |
September 30, 2021 | 81.37M |
June 30, 2021 | 74.51M |
March 31, 2021 | 66.34M |
December 31, 2020 | 65.14M |
September 30, 2020 | 62.69M |
Date | Value |
---|---|
June 30, 2020 | 61.94M |
March 31, 2020 | 61.82M |
December 31, 2019 | 63.04M |
September 30, 2019 | 63.08M |
June 30, 2019 | 52.95M |
March 31, 2019 | 41.84M |
December 31, 2018 | 27.86M |
September 30, 2018 | 16.36M |
June 30, 2018 | 13.93M |
March 31, 2018 | 12.20M |
December 31, 2017 | 11.74M |
September 30, 2017 | 19.62M |
June 30, 2017 | 179.93M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
41.84M
Minimum
Mar 2019
198.96M
Maximum
Dec 2023
87.19M
Average
68.17M
Median
Revenue (TTM) Benchmarks
United Therapeutics Corp | 2.328B |
Corcept Therapeutics Inc | 482.38M |
Cassava Sciences Inc | -- |
Amphastar Pharmaceuticals Inc | 644.40M |
Cogent Biosciences Inc | -- |